Weather

67°F10:57 AM

Health

1 read

EPA Approves New PFAS Pesticides Amid Health Concerns

KVIA•Friday, July 10, 2026 at 7:13 PM•CNN Newsource

Medical stethoscope representing healthcare news

Want the full story?

Read the complete article at KVIA

AI Summary

The U.S. Environmental Protection Agency (EPA) has recently approved three new PFAS pesticides, adding to two others approved in November 2025, totaling five under the Trump administration. Despite scientific evidence linking PFAS to serious health risks, including cancer and reproductive issues, the EPA has rolled back regulations aimed at limiting PFAS exposure. Critics, including members of the 'Make America Healthy Again' movement, are outraged by the approvals and the perceived influence of industry ties on EPA decisions. The agency has also altered its definition of PFAS, potentially allowing more chemicals to be deemed 'safe' despite concerns from health experts. This situation raises significant questions about the agency's commitment to public health and environmental safety.

Key Details: • Three new PFAS pesticides approved recently, totaling five since November 2025. • Health risks associated with PFAS include cancer, obesity, and reproductive issues. • Critics argue that industry influence is compromising public health protections. • EPA's definition changes could allow more chemicals to be classified as safe.

environment health pesticides epa pfas

People & Organizations

Environmental Working GroupLee ZeldinAmerican Chemistry CouncilCenter for Biological DiversityNathan DonleyU.S. Environmental Protection AgencyJared HayesAlexandra MunozAmerican Soybean AssociationAmerican Cleaning Institute

Related Articles

Understanding Medication Formularies: A Key to Cost-Effective Healthcare in El Paso

Navigating health insurance plans can be challenging, especially when it comes to understanding medication formularies. These formularies are lists of covered medications that can significantly impact your out-of-pocket costs. They are organized into tiers, with lower tiers typically offering lower copays. It's essential for El Paso residents to review their health plan's formulary to ensure their necessary prescriptions are covered and to avoid unexpected expenses. If a medication isn't listed, patients may need to request an exception or pay out of pocket. Knowing how to utilize this tool can lead to better healthcare decisions and savings.

Sardinia's Centenarians: Men and Women Live Equally Long in Unique Villages

In Sardinia's Blue Zone, the traditional gender longevity gap nearly disappears, with men reaching 100 years at almost the same rate as women. This phenomenon is particularly evident in the village of Villagrande Strisaili, where men slightly outnumber women among centenarians, a rarity globally. Research indicates that the gut microbiome plays a crucial role in this longevity, particularly a microbe called Akkermansia muciniphila, which is significantly more abundant in Sardinian centenarians compared to younger adults. This discovery highlights the importance of gut health and diet in aging, making it a topic of interest for further studies in longevity.

Majority of Americans Support FDA Accessibility for Popular Peptides

A recent survey by Hone Health reveals that 83% of U.S. adults familiar with peptides advocate for the FDA to allow licensed compounding pharmacies to produce seven specific peptides with a physician's prescription. The Pharmacy Compounding Advisory Committee (PCAC) will meet on July 23-24, 2026, to discuss adding these peptides to the 503A Bulks List, which would enable safer access for consumers currently relying on unregulated sources. Dr. Abid Husain emphasizes that regulated access could mitigate risks associated with gray-market peptides, which often contain harmful impurities. The decision from the FDA is expected by late 2026, with 39% of potential users indicating that reclassification would encourage them to try peptides.

El Paso's Unique Weight-Loss Program Highlights GLP-1s for Effective Management

The Hospitals of Providence Weight-Loss Program has received accreditation as the sole designated weight-loss surgery and medicine program in the El Paso region. Dr. Benjamin Clapp discussed the increasing use of GLP-1 medications for weight management during an interview, emphasizing their effectiveness alongside potential risks and side effects. This development is significant for local residents seeking weight-loss solutions, as it positions the program as a leading resource in the area. Patients considering GLP-1 treatments should be aware of both the benefits and drawbacks associated with these medications.